Dr. Small recently attended The Retina Society in San Francisco where he discussed our recent research on North Carolina Macular Dystrophy (NCMD/MCDR1). Dr. Small has been studying this disease for
Read more
-
North Carolina Macular Dystrophy (NCMD/MCDR1)
posted: Oct. 12, 2018.
Dr. Small recently attended The Retina Society in San Francisco where he discussed our recent research on North Carolina Macular Dystrophy (NCMD/MCDR1). Dr. Small has been studying this disease for
Read more
-
North Carolina Macular Dystrophy Is Caused by Dysregulation of the Retinal Transcription Factor PRDM13
posted: Sep. 13, 2018.
Purpose: To identify specific mutations causing North Carolina macular dystrophy (NCMD).Design: Whole-genome sequencing coupled with reverse transcription polymerase chain reaction (RT-PCR) analysis of gene expression in human retinal cells.Participants: A total Read more -
Macular Degeneration and Aspirin Use
posted: Sep. 13, 2018.
Purpose: To review current literature of the benefits that aspirin provides for patients’ cardiovascular health compared with the risk of AMD worsening.Methods: We performed a review and critically analyzed six cardiovascular and Read more -
CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation
posted: May 23, 2018.
Age-related macular degeneration (AMD) is the leading cause of severe vision loss in the elderly and has major economic and quality-of-life impact. Although the exact causes of AMD are not Read more -
North Carolina Macular Dystrophy presentation at AOS
posted: May 23, 2018.
Dr. Small recently attended the American Ophthalmological Society (AOS) where he discussed our recent research on North Carolina Macular Dystrophy (NCMD/MCDR1). Dr. Small has been studying this disease for more
Read more